Treatment Patterns and Prognostic Factors of Anti-HER2 Therapy in HER2-positive Advanced/Recurrent Gastric Cancer. Wada N, Kurokawa Y, Takahashi T, Saito T, et al. Anticancer Res 2026;46:949-961.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wada N, Kurokawa Y, Takahashi T, Saito T, et al. Treatment Patterns and Prognostic Factors of Anti-HER2 Therapy in HER2-positive Advanced/Recurrent Gastric Cancer. Anticancer Res 2026;46:949-961.
PMID: 41617415